Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014


ELA: Advances in Cellular Assays & Cell Culture

14 May 2014 - 15 May 2014 - Barcelona, Spain



Bookmark and Share


SELECTBIO's Advances in Cellular Assays & Cell Culture conference will focus primarily on bio-processing technologies as well as applications.  Both up-stream and down-stream bio-processing are addressed and our focus in this track is to highlight technology trends, end-user application segments, and opportunities in the application of new approaches for addressing bottlenecks in bio-processing which currently exist. SELECTBIO highlights emerging companies in this conference track and we encourage submissions from start-up and new technology entrants.
 The second part of the Advances in Cellular Assays & Cell Culture conference track will focus upon new methodologies for cellular capture including emerging trends in flow cytometry—we seek to highlight in this segment the new instrumentation for flow cytometry and novel application areas.  Here also, we encourage submissions from start-up companies and new technology providers.

Together, this conference track seeks to bring together end-users as well as technology developers to address emerging applications in cellular analysis and bioprocessing deployment.

Running alongside the Advances in Cellular Assays & Cell Culture conference will be the ELA exhibition, covering the latest technological advances and associated services from leading solution providers within this field. Registered delegates will also have access to the following co-located conference tracks, ensuring a cost effective trip: Advances in NGS & Big Data, High Content Analysis, Advances in Automation & Robotics and Advances in qPCR & dPCR.

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 02 May 2014




Further information
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!